[artículo] 
inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 185-189

Título :	Sustained response to open-label venlafaxine in drug-resistant major depression
Tipo de documento:	texto impreso
Autores:	Isaac Schweitzer, Autor ; Graham AO, Burrows, Autor ; Virginia Tuckwell, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 185-189
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos de segunda generación, Ciclohexanoles, Trastorno depresivo mayor, Resistencia a los medicamentos.
Resumen:	The aim of this study was to evaluate the response to venlafaxine in patients with treatment-resistant depression during an extension phase of an open-label study of venlafaxine. After completing the initial 8 weeks of the study, patients could continue venlafaxine treatment for an additional period of up to 10 months. Efficacy results are given for 149 patients with treatment-resistant depression.
Link:	./index.php?lvl=notice_display&id=31123

[artículo] Sustained response to open-label venlafaxine in drug-resistant major depression [texto impreso] / Isaac Schweitzer, Autor ; Graham AO, Burrows, Autor ; Virginia Tuckwell, Autor . - 2023 . - pp. 185-189.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 185-189

Palabras clave:	Antidepresivos de segunda generación, Ciclohexanoles, Trastorno depresivo mayor, Resistencia a los medicamentos.
Resumen:	The aim of this study was to evaluate the response to venlafaxine in patients with treatment-resistant depression during an extension phase of an open-label study of venlafaxine. After completing the initial 8 weeks of the study, patients could continue venlafaxine treatment for an additional period of up to 10 months. Efficacy results are given for 149 patients with treatment-resistant depression.
Link:	./index.php?lvl=notice_display&id=31123